Abstract:I am confident that the readers of these Proceedings will find something of interest, whether basic or advanced, old or new, routine or stimulating, and that all will profit from a more extensive use of the powerful, yet elegantly simple, relationships of stereology.
“…In other words, the same spherical object of 50 µm true diameter, when viewed on a random 10 µm section can produce a circular section of the object that can vary from a few µm to 50 µm. Well known statistical distributions exist for the variation of sections of a sphere (46,47). Thus when the intrinsic variation of sections of a sphere are taken into account in the observed SP sectional size variation, the result is that SP size is considerably less variable than it appears.…”
Section: Overall Size Characteristics Of Spmentioning
This paper reviews our research studies during the past 17 years on the relationship of cerebral protein dense microspheres (DMS), termed spherons, and senile plaques (SP) in the aged human brain and in AD. Initially, correlative anatomical and pathological data suggested that spherons may evolve into SP. This led to morphometric studies which strongly supported the theory. Biochemical studies were undertaken which showed that spherons could be isolated to homogeneity from brain tissue and contained the markers associated with SP. Experiments in vitro with spherons, and with inoculation of spherons into animals, reproduced SP lesion characteristics. To test the validity of using spherons for drug screening, experimental drugs were tested, a few of which are capable of blocking the formation of spheron-induced experimental SP.
“…In other words, the same spherical object of 50 µm true diameter, when viewed on a random 10 µm section can produce a circular section of the object that can vary from a few µm to 50 µm. Well known statistical distributions exist for the variation of sections of a sphere (46,47). Thus when the intrinsic variation of sections of a sphere are taken into account in the observed SP sectional size variation, the result is that SP size is considerably less variable than it appears.…”
Section: Overall Size Characteristics Of Spmentioning
This paper reviews our research studies during the past 17 years on the relationship of cerebral protein dense microspheres (DMS), termed spherons, and senile plaques (SP) in the aged human brain and in AD. Initially, correlative anatomical and pathological data suggested that spherons may evolve into SP. This led to morphometric studies which strongly supported the theory. Biochemical studies were undertaken which showed that spherons could be isolated to homogeneity from brain tissue and contained the markers associated with SP. Experiments in vitro with spherons, and with inoculation of spherons into animals, reproduced SP lesion characteristics. To test the validity of using spherons for drug screening, experimental drugs were tested, a few of which are capable of blocking the formation of spheron-induced experimental SP.
“…The reader interested in exploring stereology, both theoretical and applied, may consult Elias (1967), DeHoff and Rhines (1968), Underwood (1970), Weibel et a/. (1972) or Underwood et al (1976).…”
Procedures for inferring the internal geometric structure of an opaque bounded n-dimensional set by random sectioning are discussed. General conditions are given (evidently for the first time) for the validity of the so-called "fundamental formulae" of stereo logy (the science of inferring spatial structure from lower dimensional data). In technical terms, a wide class of unbiased ratio estimators, based on the traces of embedded features in appropriately weighted random sections, is presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.